JP2005525300A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525300A5 JP2005525300A5 JP2003537793A JP2003537793A JP2005525300A5 JP 2005525300 A5 JP2005525300 A5 JP 2005525300A5 JP 2003537793 A JP2003537793 A JP 2003537793A JP 2003537793 A JP2003537793 A JP 2003537793A JP 2005525300 A5 JP2005525300 A5 JP 2005525300A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- solvate
- salt
- compound
- yloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 10
- 239000011780 sodium chloride Substances 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 4
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 4
- 239000008249 pharmaceutical aerosol Substances 0.000 claims 3
- 239000003380 propellant Substances 0.000 claims 3
- -1 7,10,13,16-tetraoxaheptadec-1-yloxy Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 125000006545 (C1-C9) alkyl group Chemical group 0.000 claims 1
- BPXZSHHCUKRDHD-HTLUESNNSA-N (E)-but-2-enedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide;hydrate Chemical compound O.OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPXZSHHCUKRDHD-HTLUESNNSA-N 0.000 claims 1
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-Heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-Tetrafluoroethane Chemical group FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 1
- XTZNCVSCVHTPAI-UHFFFAOYSA-N 2-carboxynaphthalen-1-olate;[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]-[6-(4-phenylbutoxy)hexyl]azanium Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21.C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 XTZNCVSCVHTPAI-UHFFFAOYSA-N 0.000 claims 1
- 229940023808 Albuterol Drugs 0.000 claims 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 claims 1
- 229940092703 Beclomethasone Dipropionate Drugs 0.000 claims 1
- 229960004436 Budesonide Drugs 0.000 claims 1
- VOVIALXJUBGFJZ-VXKMTNQYSA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-VXKMTNQYSA-N 0.000 claims 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N Fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N Fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 claims 1
- 229960001888 Ipratropium Drugs 0.000 claims 1
- SONNWYBIRXJNDC-VIFPVBQESA-N Phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 claims 1
- 229960001802 Phenylephrine Drugs 0.000 claims 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N Salbutamol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims 1
- 229960005018 Salmeterol xinafoate Drugs 0.000 claims 1
- TXEYQDLBPFQVAA-UHFFFAOYSA-N Tetrafluoromethane Chemical group FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 claims 1
- 229950000210 beclometasone dipropionate Drugs 0.000 claims 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229960000289 fluticasone propionate Drugs 0.000 claims 1
- 229960000193 formoterol fumarate Drugs 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 229960002052 salbutamol Drugs 0.000 claims 1
Claims (13)
- nおよびNが、独立して、3〜6の整数を表す、請求項1記載の式(I)の化合物またはその塩もしくは溶媒和物。
- m1およびm2が、独立して、3〜9の整数を表す、請求項1または2記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R1が-C1-3アルキルまたはC1-3フルオロアルキルC0-6アルキレン-を表す、請求項1〜3のいずれか1項記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R1が-CH3、-CH2CH3、-(CH2)2CH3、-CH2(CH3)2、-CHF2、-CF3、-CH2CF3、-CH2CF2CF3または-CF2CF3を表す、請求項4記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R1が-CF3または-CH2CF3を表す、請求項5記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R2が-C1-3アルキルまたはC1-3フルオロアルキルC0-6アルキレン-を表す、請求項1〜6のいずれか1項記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R2が-CH3、-CH2CH3、-(CH2)2CH3、-CH2(CH3)2、-CHF2、-CF3、-CH2CF3、-CH2CF2CF3または-CF2CF3を表す、請求項7記載の式(I)の化合物またはその塩もしくは溶媒和物。
- R2が-CF3またはCH2CF3を表す、請求項8記載の式(I)の化合物またはその塩もしくは溶媒和物。
- 20-(7,10,13,16-テトラオキサヘプタデカ-1-イルオキシ)-2,5,8,11,18-ペンタオキサヘンイコサン-21-酸、
38-(7,10,13,16,19,22,25,28,31,34-デカオキサペンタトリアコンタ-1-イルオキシ)-2,5,8,11,14,17,20,23,26,29,36-ウンデカオキサノナトリアコンタン-39-酸、
17-(4,7,10,13-テトラオキサテトラデカ-1-イルオキシ)-2,5,8,11,15-ペンタオキサオクタデカン-18-酸および
35-(4,7,10,13,16,19,22,25,28,31-デカオキサドトリアコンタ-1-イルオキシ)-2,5,8,11,14,17,20,23,26,29,33-ウンデカオキサヘキサトリアコンタン-36-酸から選ばれる式(I)の化合物またはその塩もしくは溶媒和物。 - 微粒子状医薬、フルオロカーボンもしくは水素含有クロロフルオロカーボン噴射剤またはそれらの混合物、および請求項1〜10のいずれか1項記載の式(I)の化合物を含んでなる医薬エアゾール剤。
- 前記噴射剤が、1,1,1,2-テトラフルオロエタン、1,1,1,2,3,3,3-ヘプタフルオロ-n-プロパンまたはそれらの混合物から選ばれる、請求項11記載の医薬エアゾール剤。
- エフェドリンおよびテオフィリン;フェノテロールおよびイプラトロピウム;イソエタリンおよびフェニレフリン;アルブテロールおよびジプロピオン酸ベクロメタゾン;ブデソニドおよびフマル酸ホルモテロール;ならびにサルメテロール キシナホアート(salmeterol xinafoate)およびプロピオン酸フルチカゾンから選ばれる2以上の微粒子状医薬の組合せを含有する、請求項11または12記載の医薬エアゾール剤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0125127.1A GB0125127D0 (en) | 2001-10-19 | 2001-10-19 | Compounds |
PCT/EP2002/011635 WO2003035237A2 (en) | 2001-10-19 | 2002-10-17 | Compounds for use as surfactants |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005525300A JP2005525300A (ja) | 2005-08-25 |
JP2005525300A5 true JP2005525300A5 (ja) | 2006-01-05 |
JP4223954B2 JP4223954B2 (ja) | 2009-02-12 |
Family
ID=9924153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003537793A Expired - Fee Related JP4223954B2 (ja) | 2001-10-19 | 2002-10-17 | 界面活性剤として使用するための化合物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7321059B2 (ja) |
EP (1) | EP1436007B1 (ja) |
JP (1) | JP4223954B2 (ja) |
AT (1) | ATE291928T1 (ja) |
AU (1) | AU2002340578A1 (ja) |
DE (1) | DE60203528T2 (ja) |
ES (1) | ES2238606T3 (ja) |
GB (1) | GB0125127D0 (ja) |
WO (1) | WO2003035237A2 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003059317A2 (en) | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
US7217833B2 (en) | 2002-02-13 | 2007-05-15 | Glaxco Group Limited | Carboxylic acid compounds for use as surfactants |
CN102416179B (zh) | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
US10676658B2 (en) | 2017-08-15 | 2020-06-09 | Saudi Arabian Oil Company | Oil-based drilling fluids for high pressure and high temperature drilling operations |
WO2019036290A1 (en) | 2017-08-15 | 2019-02-21 | Saudi Arabian Oil Company | THERMALLY STABLE SURFACTANTS FOR OIL BASED DRILLING FLUIDS |
US10640696B2 (en) | 2017-08-15 | 2020-05-05 | Saudi Arabian Oil Company | Oil-based drilling fluids for high pressure and high temperature drilling operations |
US10745606B2 (en) | 2017-08-15 | 2020-08-18 | Saudi Arabian Oil Company | Oil-based drilling fluid compositions which include layered double hydroxides as rheology modifiers |
US10647903B2 (en) | 2017-08-15 | 2020-05-12 | Saudi Arabian Oil Company | Oil-based drilling fluid compositions which include layered double hydroxides as rheology modifiers and amino amides as emulsifiers |
US10793762B2 (en) | 2017-08-15 | 2020-10-06 | Saudi Arabian Oil Company | Layered double hydroxides for oil-based drilling fluids |
US10988659B2 (en) | 2017-08-15 | 2021-04-27 | Saudi Arabian Oil Company | Layered double hydroxides for oil-based drilling fluids |
US10876039B2 (en) | 2017-08-15 | 2020-12-29 | Saudi Arabian Oil Company | Thermally stable surfactants for oil based drilling fluids |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352789A (en) | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
DE3903663C1 (ja) * | 1989-02-08 | 1990-09-27 | Huels Ag, 4370 Marl, De | |
IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
AU654813B2 (en) | 1990-03-23 | 1994-11-24 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
WO1992000062A1 (en) | 1990-06-27 | 1992-01-09 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
US5126123A (en) * | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
BR9106595A (pt) | 1990-06-29 | 1993-04-20 | Fisons Plc | Composicao aerossol pressurizada |
US5376359A (en) | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
GB9419536D0 (en) | 1994-09-28 | 1994-11-16 | Glaxo Inc | Medicaments |
US6451287B1 (en) | 2000-05-26 | 2002-09-17 | Smithkline Beecham Corporation | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
US7217409B2 (en) * | 2000-09-22 | 2007-05-15 | Smithkline Beecham Corporation | Alkanoic acid derivatives |
WO2003013610A2 (en) * | 2001-08-03 | 2003-02-20 | Glaxo Group Limited | Surfactant compounds and uses thereof |
-
2001
- 2001-10-19 GB GBGB0125127.1A patent/GB0125127D0/en not_active Ceased
-
2002
- 2002-10-17 ES ES02774728T patent/ES2238606T3/es not_active Expired - Lifetime
- 2002-10-17 AT AT02774728T patent/ATE291928T1/de not_active IP Right Cessation
- 2002-10-17 DE DE60203528T patent/DE60203528T2/de not_active Expired - Fee Related
- 2002-10-17 AU AU2002340578A patent/AU2002340578A1/en not_active Abandoned
- 2002-10-17 EP EP02774728A patent/EP1436007B1/en not_active Expired - Lifetime
- 2002-10-17 JP JP2003537793A patent/JP4223954B2/ja not_active Expired - Fee Related
- 2002-10-17 US US10/492,606 patent/US7321059B2/en not_active Expired - Fee Related
- 2002-10-17 WO PCT/EP2002/011635 patent/WO2003035237A2/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005525300A5 (ja) | ||
RU97106511A (ru) | Фармацевтическая аэрозольная композиция, способ изготовления такой композиции, способ лечения респираторных заболеваний, поверхностно-активное вещество для таких композиций и способ его получения | |
ES2652604T3 (es) | Composiciones azeotrópicas que comprenden compuestos fluorados para aplicaciones de limpieza | |
JP5430977B2 (ja) | 2−クロロ−3,3,3−トリフルオロプロペン(HCFC−1233xf)およびフッ化水素(HF)の共沸様組成物 | |
JPH05505824A (ja) | 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用 | |
KR970705981A (ko) | 약제(Medicaments) | |
JP2004509159A5 (ja) | ||
JP2004509159A (ja) | 新規なアルカン酸誘導体 | |
CA2608166A1 (en) | Method for producing fluorinated organic compounds | |
WO1998036449A1 (fr) | Gaz d'attaque et de nettoyage | |
JP4223954B2 (ja) | 界面活性剤として使用するための化合物 | |
JP2006008695A (ja) | 界面活性剤化合物およびその使用 | |
JP2005529102A5 (ja) | ||
JP2008523175A5 (ja) | ||
JP2009500310A5 (ja) | ||
JP2005526149A5 (ja) | ||
AU2002321422A1 (en) | Surfactant compounds and uses thereof | |
JP2001192347A (ja) | ペルフルオロアルカジエンの製造方法 | |
JP2005517701A5 (ja) | ||
JP2005517701A (ja) | 界面活性剤として使用するためのカルボン酸化合物 | |
EP1480990B1 (en) | Compounds for use as surfactants | |
JPH069448A (ja) | ヒドロフルオロアルカンの安定化法及び少なくとも1つのヒドロフルオロアルカンを含む組成物 | |
JPWO2020231776A5 (ja) | ||
JP2022166272A5 (ja) | ||
JP2005501896A (ja) | Cf3基を含有する化合物の製造方法 |